ABSTRACT
Boosted by the COVID-19 pandemic, as well as the tightened General Data Protection Regulation (GDPR) legislation within the European Union (EU), individuals have become increasingly concerned about privacy. This is also reflected in how willing individuals are to consent to sharing personal data, including their health data. To understand this behaviour better, this study focuses on willingness to consent in relation to genomic data. The study explores how the provision of educational information relates to willingness to consent, as well as differences in privacy concerns, information sensitivity and the perceived trade-off value between individuals willing versus unwilling to consent to sharing their genomic data. Of the respondents, 65% were initially willing to consent, but after educational information 89% were willing to consent and only 11% remained unwilling to consent. Educating individuals about potential health benefits can thus help to correct the beliefs that originally led to the unwillingness to share genomic data.
Subject(s)
COVID-19 , Genetic Privacy , Genomics , Humans , Delivery of Health Care , Pandemics , Informed ConsentABSTRACT
The aim of this paper is to contribute to knowledge about the expansion of eCommerce (eCom) operations by small and medium-sized enterprises (SMEs) to global markets. We investigate the literature on eCom and reflect on our experiences working with several Finnish eCom companies and consulting firms to boost their global sales. In addition, one important goal of our study was to acquire knowledge and boost participants learning of fast-growing digital business models. Our findings show that digital disruption and digitalization in general are driving forces behind eCom growth. The studys conclusions underline the importance of targeted marketing activities, knowledge sharing, and capability building for global eCom operations.